Journal article

Publication year: 2006

Pages: 310-316

Journal: Oncogene

Volume number: 25

Issue number: 2

ISSN: 0950-9232

DOI Link: https://doi.org/10.1038/sj.onc.1209001

Publisher: Springer Nature [academic journals on nature.com]

Abstract: 
RASSF1A is a tumor suppressor gene on 3p21.3 frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma (NPC). To identify RASSF1A target genes in NPC, we have investigated the expression pro. le of the stable RASSF1A transfectants and controls by high-density oligonucleotide array. A total of 57 genes showed differential expression in the RASSF1A-expressing cells. These RASSF1A target genes were involved in multiple cellular regulatory processes such as transcription, signal transduction, cell adhesion and RNA processing. The RASSF1A-modulated expression of eight selected genes with the highest fold changes (ATF5, TCRB, RGS1, activin beta E, HNRPH1, HNRPD, Id2 and CKS2) by RASSF1A was confirmed in both stable and transient transfectants. Compared with the RASSF1A transfectants, an inverse expression pattern of activin bE, Id2 and ATF5 was shown in the immortalized nasopharyngeal epithelial cells treated with siRNA against RASSF1A. The findings imply that the expression of activin bE, Id2 and ATF5 was tightly regulated by RASSF1A and may associate with its tumor suppressor function. Strikingly, overexpression of Id2 is common in NPC and RASSF1A-induced repression of Id2 was mediated by the overexpression of activin bE. The results suggest a novel RASSF1A pathway in which both activin bE and Id2 are involved.

Harvard Citation style: Chow, L., Lam, C., Chan, S., Tsao, S., To, K., Tong, S., et al. (2006) Identification of RASSF1A modulated genes in nasopharyngeal carcinoma, Oncogene, 25(2), pp. 310-316. https://doi.org/10.1038/sj.onc.1209001

APA Citation style: Chow, L., Lam, C., Chan, S., Tsao, S., To, K., Tong, S., Hung, W., Dammann, R., Huang, D., & Lo, K. (2006). Identification of RASSF1A modulated genes in nasopharyngeal carcinoma. Oncogene. 25(2), 310-316. https://doi.org/10.1038/sj.onc.1209001